Contineum Therapeutics, Inc.
CTNM
Revenue
0.00
▼-50.00M▼-100.00%
12 Months ChangeAssets
221.36M
▲97.79M▲79.14%
3 Months ChangeLiabilities
3.85M
▼-2.72M▼-41.40%
3 Months ChangeFree Cash Flow
-8.12M
▼-2.83M▼-53.36%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001437749-24-026680
2024-08-13
Form 8-K
ID: 0001437749-24-026385
2024-06-24
Form 8-K
ID: 0001437749-24-021083
2024-05-31
Form 8-K
ID: 0001437749-24-018934
2024-05-20
Form 8-K
ID: 0001437749-24-017651
2024-05-16
Form 10-Q
ID: 0001437749-24-017320
2024-05-16
Form 8-K
ID: 0001437749-24-017293
2024-04-09
Form 8-K
ID: 0001193125-24-090917